Arcutis (ARQT) EVP Patrick Burnett Sells 1,697 Shares

What Happened Patrick Burnett, Executive Vice President and Chief Medical Officer of Arcutis Biotherapeutics (ARQT), sold 1,697 shares on 2026-08-19 at $27.00 per share, netting $45,819. The filing indicates this disposition was to cover tax withholding related to the vesting of restricted stock units (RSUs), so it represents a routine tax-related sale rather than a discretionary market sale.

Key Details

• Transaction date and price: 2026-08-19, 1,697 shares sold at $27.00 each (total $45,819).
• Transaction type: Sale (code S); footnote indicates tax withholding (code/footnote F1).
• Reason: Shares sold to satisfy tax withholding obligations on RSU vesting.
• Filing date: 2026-08-21 — appears to be filed within the normal 2-business-day Form 4 window.
• Shares owned after transaction: Not specified in the provided filing details.

Context Sales made to cover tax withholding on vested equity are common and generally considered routine—they do not necessarily indicate the insider's view on the company's prospects. Purchases tend to carry more weight for signaling insider confidence; this report documents a tax-driven disposition.